NCT05021419View on ClinicalTrials.gov

Efficacy of a Streamlined Heart Failure Optimization Protocol

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 17, 2022

Primary Completion Date

January 7, 2024

Study Completion Date

January 7, 2024

Conditions
Heart Failure with Reduced Ejection FractionChronic Heart Failure
Interventions
OTHER

Streamlined protocol

A streamlined drug protocol for optimizing heart failure medication

OTHER

Standard Protocol

Current standard optimization protocol as per NICE and ESC

Trial Locations (1)

PE30 4ET

Queen Elizabeth Hospital King's Lynn, Kings Lynn

Sponsors

Collaborators (1)

Novartis Pharmaceuticals
All Listed Sponsors
collaborator

Novartis Pharmaceuticals

INDUSTRY

lead

The Queen Elizabeth Hospital King's Lynn NHS Foundation Trust

OTHER